Examples of using Multicentre in English and their translations into Norwegian
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The hotel is a part of The Multicentre Vågen Amfi,
efficacy of Pixuvri as single-agent therapy were evaluated in a multicentre, randomised, active controlled trial in patients with relapsed
The difference between treatment groups in the average weekly frequency of≥3 SCBMs per week was not statistically significant over Weeks 1-12 which is inconsistent with the 5 other multicentre, randomised, double-blind, 12-week placebo controlled studies demonstrating efficacy at this timepoint in adult patients.
Two Phase II multicentre, randomised, double-masked, parallel group studies were conducted in Japan, and two Phase III multicentre, randomised(2:1), double-masked, parallel group, placebo- controlled studies were conducted
In the multicentre, open-label, single arm VIKING-3 study(ING112574), HIV-1 infected,
open-label, multicentre prospective study comparing the NNRTIs nevirapine,
The clinical efficacy of Esbriet has been studied in four Phase 3, multicentre, randomised, double-blind,
An open-label, multicentre, international, randomised phase III study supports the use of vemurafenib in previously untreated patients with BRAF V600E mutation-positive unresectable or metastatic melanoma.
TRITON was a 13,608 patient, multicentre international, randomised,
Phase III multicentre.
In the adjuvant treatment setting, Herceptin was investigated in 4 large multicentre, randomised, trials.
open-label, multicentre, parallel-group study in.
results of a multicentre, randomized, double-blind,
Two controlled, multicentre, randomised, double blind parallel group,
An international open-label, multicentre, randomised, comparative Phase III study was conducted in adult patients with newly diagnosed chronic phase CML.
Two Phase III randomised, multicentre, double-blind, placebo-controlled studies were conducted in patients with cervical dystonia.
randomised, multicentre Phase III study(DACO-016)
Efficacy was established in two randomised placebo-controlled multicentre phase 3 clinical studies(studies 301 and 302) of patients with metastatic castration resistant prostate cancer.
The included study was a phase III multicentre, double-blinded randomized controlled trial(JMEN study) published by Ciuleanu et al.
One large, open-label, multicentre, international randomised phase III study has been conducted in patients with newly diagnosed Ph+ CML.